Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 580240, 10 pages
http://dx.doi.org/10.1155/2015/580240
Research Article

Identification and Characterization of a Serious Multidrug Resistant Stenotrophomonas maltophilia Strain in China

1Department of Critical Care Medicine, Affiliated Hospital of Academy of Military Medical Science, Beijing 100071, China
2The Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
3Department of Respiratory Diseases, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, China
4Jinan Fourth People’s Hospital, Jinan 250031, Shandong, China
5Beijing Institute of Biotechnology, Beijing 100071, China

Received 24 August 2014; Accepted 1 December 2014

Academic Editor: Thomas Lufkin

Copyright © 2015 Yan Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Ryan, S. Monchy, M. Cardinale et al., “The versatility and adaptation of bacteria from the genus Stenotrophomonas,” Nature Reviews Microbiology, vol. 7, no. 7, pp. 514–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Brooke, “Stenotrophomonas maltophilia: an emerging global opportunistic pathogen,” Clinical Microbiology Reviews, vol. 25, no. 1, pp. 2–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Calza, R. Manfredi, and F. Chiodo, “Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study,” Infection, vol. 31, no. 3, pp. 155–161, 2003. View at Google Scholar · View at Scopus
  4. P. Naidu and S. Smith, “A review of 11 years of Stenotrophomonas maltophilia blood isolates at a tertiary care institute in Canada,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 23, no. 4, pp. 165–169, 2012. View at Google Scholar · View at Scopus
  5. V. J. Waters, M. I. Gómez, G. Soong, S. Amin, R. K. Ernst, and A. Prince, “Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia,” Infection and Immunity, vol. 75, no. 4, pp. 1698–1703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nseir, C. Di Pompeo, H. Brisson et al., “Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome,” Critical Care, vol. 10, no. 5, article R143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Samonis, D. E. Karageorgopoulos, S. Maraki et al., “Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome,” PLoS ONE, vol. 7, no. 5, Article ID e37375, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-N. Jang, F.-D. Wang, L.-S. Wang, C.-H. Liu, and I.-M. Liu, “Xanthomonas maltophilia bacteremia: an analysis of 32 cases,” Journal of the Formosan Medical Association, vol. 91, no. 12, pp. 1170–1176, 1992. View at Google Scholar · View at Scopus
  9. M. A. Victor, M. Arpi, B. Bruun, V. Jonsson, and M. M. Hansen, “Xanthomonas maltophilia bacteremia in immunocompromised hematological patients,” Scandinavian Journal of Infectious Diseases, vol. 26, no. 2, pp. 163–170, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. L. C. Crossman, V. C. Gould, J. M. Dow et al., “The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants,” Genome Biology, vol. 9, no. 4, article R74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-C. Tseng, W.-F. Fang, K.-T. Huang et al., “Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia,” Infection Control and Hospital Epidemiology, vol. 30, no. 12, pp. 1193–1202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. V. C. Gould, A. Okazaki, and M. B. Avison, “Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 1, pp. 655–657, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Sassera, I. Leardini, L. Villa et al., “Draft genome sequence of Stenotrophomonas maltophilia strain EPM1, found in association with a culture of the human parasite Giardia duodenalis,” Genome Announcements, vol. 1, no. 2, Article ID e00182-13, 2013. View at Publisher · View at Google Scholar
  14. A. Chauhan, S. Green, A. Pathak, J. Thomas, and R. Venkatramanan, “Whole-genome sequences of five oyster-associated bacteria show potential for crude oil hydrocarbon degradation,” Genome Announcements, vol. 1, no. 5, Article ID e00802-13, 2013. View at Publisher · View at Google Scholar
  15. F. Lira, A. Hernández, E. Belda et al., “Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain,” Journal of Bacteriology, vol. 194, no. 13, pp. 3563–3564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Zhang, M. Morrison, P. O. Cuív, P. Evans, and C. M. Rickard, “Genome sequence of Stenotrophomonas maltophilia strain AU12-09, isolated from an intravascular catheter,” Genome Announcements, vol. 1, no. 3, 2013. View at Publisher · View at Google Scholar
  17. R. Banerjee and D. Roy, “Codon usage and gene expression pattern of Stenotrophomonas maltophilia R551-3 for pathogenic mode of living,” Biochemical and Biophysical Research Communications, vol. 390, no. 2, pp. 177–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Adamek, J. Overhage, S. Bathe, J. Winter, R. Fischer, and T. Schwartz, “Genotyping of environmental and clinical Stenotrophomonas maltophilia isolates and their pathogenic potentia,” PLoS ONE, vol. 6, no. 11, Article ID e27615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Delcher, A. Phillippy, J. Carlton, and S. L. Salzberg, “Fast algorithms for large-scale genome alignment and comparison,” Nucleic Acids Research, vol. 30, no. 11, pp. 2478–2483, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. G. McArthur, N. Waglechner, F. Nizam et al., “The comprehensive antibiotic resistance database,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 7, pp. 3348–3357, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. L. L. Chang, H. F. Chen, C. Y. Chang, T. M. Lee, and W. J. Wu, “Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia,” Journal of Antimicrobial Chemotherapy, vol. 53, no. 3, pp. 518–521, 2004. View at Publisher · View at Google Scholar
  22. H. W. Stokes and R. M. Hall, “A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons,” Molecular Microbiology, vol. 3, no. 12, pp. 1669–1683, 1989. View at Publisher · View at Google Scholar · View at Scopus
  23. A. C. Fluit and F. J. Schmitz, “Class 1 integrons, gene cassettes, mobility, and epidemiology,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 18, no. 11, pp. 761–770, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Barbolla, M. Catalano, B. E. Orman et al., “Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 2, pp. 666–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Toleman, P. M. Bennett, D. M. C. Bennett, R. N. Jones, and T. R. Walsh, “Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes,” Emerging Infectious Diseases, vol. 13, no. 4, pp. 559–565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. Jacoby, “Mechanisms of resistance to quinolones,” Clinical Infectious Diseases, vol. 41, supplement 2, pp. S120–S126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Alonso and J. L. Martínez, “Multiple antibiotic resistance in Stenotrophomonas maltophilia,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 5, pp. 1140–1142, 1997. View at Google Scholar · View at Scopus
  28. L. McMurry, R. E. Petrucci Jr., and S. B. Levy, “Active efflux of tetracycline encoded by four genetically different tetracyline resistance determinants in Escherichia coli,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 7, pp. 3974–3977, 1980. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Martinez, M. B. Sánchez, L. Martínez-Solano et al., “Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems,” FEMS Microbiology Reviews, vol. 33, no. 2, pp. 430–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ferrer-Navarro, R. Planell, D. Yero et al., “Abundance of the quorum-sensing factor Ax21 in four strains of correlates with mortality rate in a New Zebrafish model of infection,” PLoS ONE, vol. 8, no. 6, Article ID e67207, 2013. View at Publisher · View at Google Scholar
  31. S. W. Han, S. W. Lee, and P. C. Ronald, “Secretion, modification, and regulation of Ax21,” Current Opinion in Microbiology, vol. 14, no. 1, pp. 62–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Lee SW, S. W. Han, M. Sririyanum, C. J. Park, Y. S. Seo, and P. C. Ronald, “A type I-secreted, sulfated peptide triggers XA21-mediated innate immunity,” Science, vol. 326, no. 5954, pp. 850–853, 2009. View at Google Scholar
  33. Y. McCarthy, J. M. Dow, and R. P. Ryan, “The Ax21 protein is a cell-cell signal that regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia,” Journal of Bacteriology, vol. 193, no. 22, pp. 6375–6378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Kaiser, K. Biehler, and D. Jonas, “A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structured,” Journal of Bacteriology, vol. 191, no. 9, pp. 2934–2943, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. B. Sánchez, A. Hernández, J. M. Rodríguez-Martínez, L. Martínez-Martínez, and J. L. Martínez, “Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants,” BMC Microbiology, vol. 8, article 148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Ng and W.-J. Lin, “Comparison of assembled Clostridium botulinum A1 genomes revealed their evolutionary relationship,” Genomics, vol. 103, no. 1, pp. 94–106, 2014. View at Publisher · View at Google Scholar